Must read stories related to VRX stock, UA stock, RAD stock, TGTX stock, and NOK stock, along with details on a new service.
Bill Ackman may look like a joke now by selling VRX stock at $11. Investors need to consider why he walked away now from Valeant Pharmaceuticals (NYSE:VRX)
VRX stock is upgraded at $12 behind false narrative for Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and inevitable upside.
The narrative with Valeant Pharmaceuticals (NYSE:VRX) and VRX stock will soon change, just as it did for Sprint Corp (NYSE:S) and Sprint stock.
Valeant Pharmaceuticals (NYSE:VRX) earnings weren’t that bad; debt reduction is a real catalyst; and VRX stock could double and still be cheap.
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) Stock Outlook Improves Behind Trulance Catalysts & Recent Developments
SGYP stock may finally be a good buy after Synergy Pharmaceuticals offering, Linzess’ label change, and smart recruiting from Valeant Pharmaceuticals
Alkermes stock, VRX stock, Acadia Pharmaceuticals, and Vertex Pharmaceuticals were all discussed in our first Biotech Hunter.